UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

The Lancet (British edition), 2016-12, Vol.388 (10062), p.2873-2884

2016

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2015-12, Vol.40 (13), p.3053-3060

2015

Volltextzugriff (PDF)

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Journal of Alzheimer's disease, 2018-01, Vol.61 (1), p.435-457

2018

Volltextzugriff (PDF)

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Neural plasticity, 2022-11, Vol.2022, p.2104880-13

2022

Volltextzugriff (PDF)

Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke

Stroke (1970), 2014-11, Vol.45 (11), p.3304-3310

2014

Volltextzugriff (PDF)

The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators

Journal of Alzheimer's disease, 2023-01, Vol.92 (1), p.1-12

2023

Volltextzugriff (PDF)

Diagnostic criteria for apathy in neurocognitive disorders

Alzheimer's & dementia, 2021-12, Vol.17 (12), p.1892-1904

2021

Volltextzugriff (PDF)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial

Journal of Alzheimer's disease, 2022, Vol.86 (3), p.1399-1413

2022

Volltextzugriff (PDF)

Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

Journal of Alzheimer's disease, 2020-01, Vol.75 (2), p.501-519

2020

Volltextzugriff (PDF)

Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis

Journal of Alzheimer's disease, 2024-04, Vol.98 (4), p.1483-1491

2024

Volltextzugriff (PDF)

Memantine in Moderate-to-Severe Alzheimer's Disease

The New England journal of medicine, 2003-04, Vol.348 (14), p.1333-1341

2003

Volltextzugriff (PDF)

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

The Journal of biological chemistry, 2003-03, Vol.278 (13), p.10963-10972

2003

Volltextzugriff (PDF)

Microscopic Examination of Iatrogenic Subglottic Tracheal Stenosis: Observations That May Elucidate Its Histopathologic Origin

Annals of otology, rhinology & laryngology, 2014-01, Vol.123 (1), p.25-31

2014

Volltextzugriff (PDF)

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

The Journal of nutrition, health & aging, 2012-04, Vol.16 (4), p.339-345

2012

Volltextzugriff (PDF)

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease

Archives of neurology (Chicago), 2006-01, Vol.63 (1), p.49

2006

Volltextzugriff (PDF)

New Approaches to Clinical Trials in Vascular Dementia: Memantine in Small Vessel Disease

Cerebrovascular diseases (Basel, Switzerland), 2002-01, Vol.13 (Suppl 2), p.61-66

2002

Volltextzugriff (PDF)

T cell activation by monoclonal antibodies bound to tumor cells by a cell surface displayed single-chain antibody

Journal of immunological methods, 1999-04, Vol.224 (1), p.151-160

1999

Volltextzugriff (PDF)

Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer

Journal of surgical oncology, 1996-01, Vol.61 (1), p.42-48

1996

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke

The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators

Diagnostic criteria for apathy in neurocognitive disorders

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial

Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis

Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock

Memantine in Moderate-to-Severe Alzheimer's Disease

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

Microscopic Examination of Iatrogenic Subglottic Tracheal Stenosis: Observations That May Elucidate Its Histopathologic Origin

Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease

New Approaches to Clinical Trials in Vascular Dementia: Memantine in Small Vessel Disease

T cell activation by monoclonal antibodies bound to tumor cells by a cell surface displayed single-chain antibody

Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer

Aktive Filter

Suchergebnisse filtern